OncoTherapy Science, Inc.

4564

JP3202150003

Biotechnology & Medical Research

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-22 am EDT			5-day change	1st Jan Change
15 ^JPY	-6.25%		-6.25%	-34.78%

Apr. 29	Poland's Tusk calls prosecutor over potential Orlen scandal	RE
Apr. 22	OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	CI

OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm

April 27, 2021

On April 28, 2021, OncoTherapy Science, Inc. (TSE:4564) closed the transaction.

Latest news about OncoTherapy Science, Inc.

Poland's Tusk calls prosecutor over potential Orlen scandal	Apr. 29	RE
OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	Apr. 21	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor	Apr. 04	CI
OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index	23-09-18	CI
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
OncoTherapy Science, Inc. announced that it has received ¥95.95 million in funding	23-04-09	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥95.95 million in funding	23-03-23	CI
OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	21-04-27	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	21-04-11	CI
OncoTherapy Science, Inc. announced that it has received ¥12.013 million in funding from Daiwa Securities Group Inc.	19-01-14	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥12.013 million in funding from Daiwa Securities Group Inc.	18-12-25	CI
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company	17-07-13	CI
OncoTherapy Science, Inc.(TSE:4564) added to Russell Global Index	15-06-29	CI
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A	13-07-30	CI
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines	12-04-01	CI

Chart OncoTherapy Science, Inc.

Duration

Period

More charts

OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.

Sector

Biotechnology & Medical Research

Calendar

2024-08-01 - Q1 2025 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
ONCOTHERAPY SCIENCE, INC.	-34.78%	22.92M
VERTEX PHARMACEUTICALS INCORPORATED	+8.63%	114B
REGENERON PHARMACEUTICALS, INC.	+13.17%	107B
BIONTECH SE	-12.76%	22.22B
ARGENX SE	-3.11%	21.28B
BEIGENE, LTD.	-7.19%	17.51B
WUXI APPTEC CO., LTD.	-39.93%	17.17B
NEUROCRINE BIOSCIENCES, INC.	+6.67%	14.14B
SAREPTA THERAPEUTICS, INC.	+33.90%	12.2B
LEGEND BIOTECH CORPORATION	-28.60%	7.83B

Bio Therapeutic Drugs